Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Recipharm Gets Medchem Provider

by Rick Mullin
June 22, 2015 | A version of this story appeared in Volume 93, Issue 25

Recipharm has acquired OnTarget Chemistry, a Swedish contract research organization specializing in medicinal chemistry with expertise in synthesis and analytical services. The deal gives Recipharm, a contract development and manufacturing firm, preclinical chemistry services, allowing it to engage with customers at early stages of drug development. Recipharm will pay $1.8 million, half in cash and the rest in stock. OnTarget had sales last year of about $3.5 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.